Published in J Surg Oncol on October 01, 2000
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol (2012) 1.82
Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers. Int J Colorectal Dis (2010) 1.24
Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Res (2012) 1.12
Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. Int J Colorectal Dis (2008) 1.12
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today (2008) 1.11
Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. Gastroenterol Res Pract (2012) 0.98
Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. Br J Cancer (2005) 0.96
Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis (2003) 0.93
Mucinous colorectal carcinoma. J Surg Oncol (2001) 0.90
Effect of mucin production on survival in colorectal cancer: a case-control study. World J Gastroenterol (2008) 0.88
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist (2010) 0.88
The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol (2012) 0.86
Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol (2015) 0.86
Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma. Surg Today (2014) 0.81
Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer. Clin Exp Metastasis (2007) 0.81
Colon carcinoma in childhood: review of the literature with four case reports. Int J Colorectal Dis (2012) 0.81
A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: a 26-year retrospective study in China. PLoS One (2015) 0.80
Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma. Intest Res (2015) 0.79
Mucinous carcinoma of the rectum: a distinct clinicopathological entity. Tech Coloproctol (2013) 0.79
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report. BMC Cancer (2015) 0.78
A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery. World J Surg Oncol (2011) 0.77
DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment. Oncogene (2015) 0.76
Significance of the mucinous component in the histopathological classification of colon cancer. Surg Today (2015) 0.75
Macroscopic serosal classification of colorectal cancer and its clinical significance. Int J Clin Exp Med (2015) 0.75
Five-point scoring system based on clinicopathological data: A convenient criterion to determine prognosis of patients with colorectal carcinoma. Oncol Lett (2013) 0.75
Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer. Mod Pathol (2016) 0.75
[Clinical, pathological and molecular prognostic factors in colorectal carcinomas]. Pathologe (2003) 0.75
Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy. Surg Today (2016) 0.75
The potential predictive value of MRI and PET-CT in Mucinous and Nonmucinous Rectal Cancer to identify patients at high risk of metastatic disease. Br J Radiol (2016) 0.75
Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc (1994) 6.86
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer (1998) 3.81
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg (1992) 2.48
Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg (1988) 2.31
A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc (2000) 2.30
Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell (1999) 2.26
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg (2000) 2.13
Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg (1994) 2.13
Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS. Neurology (2011) 2.09
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer (2000) 2.08
Bile leakage after hepatic resection. Ann Surg (2001) 2.08
Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg (1984) 2.07
Real-space observation of current-driven domain wall motion in submicron magnetic wires. Phys Rev Lett (2004) 1.99
Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer (2000) 1.93
Needle and trocar injury during laparoscopic surgery in Japan. Surg Endosc (1997) 1.92
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg (2001) 1.90
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
Solitary Peutz-Jeghers type polyp of the stomach in the absence of familial polyposis coli in a teenage boy. Endoscopy (1989) 1.86
Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery (1995) 1.82
Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg (1981) 1.79
Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg (1992) 1.76
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg (1997) 1.76
Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy (2008) 1.73
Predictors of lymph node metastasis in early gastric cancer. Br J Surg (1992) 1.73
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology (1995) 1.72
Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg (1997) 1.71
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer (1997) 1.67
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67
Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology (1996) 1.64
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol (2002) 1.64
Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology (1991) 1.63
Gastric carcinoma in patients over 70 years of age. Br J Surg (1995) 1.59
Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology (1989) 1.58
Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol (1995) 1.57
Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery (2000) 1.55
Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol (2001) 1.54
A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology (1989) 1.53
Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg (1989) 1.53
Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer (1996) 1.52
Laparoscopic splenectomy. Am J Surg (1994) 1.52
Alternate hemihepatic vascular control technique for hepatic resection. Am J Surg (1993) 1.51
Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology (1994) 1.51
Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg (1988) 1.50
Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc (1992) 1.49
Usefulness of preoperative transvaginal ultrasonography for women with advanced gastric carcinoma. Am J Gastroenterol (1999) 1.49
Changes in the caudate lobe that is transplanted with extended left lobe liver graft from living donors. Surgery (2001) 1.49
Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg (1990) 1.46
Results of 280 liver resections for hepatocellular carcinoma. Arch Surg (1996) 1.45
Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol (1992) 1.45
Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer (2000) 1.45
Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer (2001) 1.44
Signet ring cell carcinoma of the stomach. Cancer (1992) 1.44
Endothelium-derived relaxing factor and vein grafts. Br J Surg (1991) 1.43
Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology (1992) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
Transitional mucosa in human colorectal lesions. Dis Colon Rectum (1990) 1.42
Laparoscopic repair for perforation of duodenal ulcer with omental patch: report of initial six cases. Surg Laparosc Endosc (1998) 1.42
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A (1998) 1.42
Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery (1996) 1.41
Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery (1988) 1.41
Laparoscopic splenectomy with an ultrasonic dissector. N Engl J Med (1992) 1.41
Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer (1996) 1.41
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res (2000) 1.40
Acute gastric anisakiasis. Analysis of 178 cases. JAMA (1985) 1.40
p27 expression and gastric carcinoma. Nat Med (1997) 1.40
Graft replacement of pararenal inferior vena cava for leiomyosarcoma with the use of venous bypass. Surgery (1993) 1.40
Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg (1998) 1.40
Endoscopic classification of gastric varices. Gastrointest Endosc (1990) 1.39
Non-penetrating vascular clips anastomosis inhibited intimal thickening under poor runoff conditions in canine autogenous vein grafts. Eur J Vasc Endovasc Surg (2001) 1.39
Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg (1995) 1.39
Technical and theoretic considerations in continuous end-to-end vascular anastomosis. J Vasc Surg (1994) 1.37
Laparoscopic hepatectomy for hepatocellular carcinoma. Surg Endosc (2001) 1.37
Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer (1996) 1.36
Vascular anatomy of duodenal varices: angiographic and histopathological assessments. Am J Gastroenterol (1993) 1.36
Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol (1997) 1.35
Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol (1999) 1.35
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res (2001) 1.33
A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene (2001) 1.33
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg (1995) 1.33
Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res (1990) 1.33
Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases. Cancer (1996) 1.32
Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg (1997) 1.31
Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res (1990) 1.30
The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer (1993) 1.29
L-Aspartate oxidase, a newly discovered enzyme of Escherichia coli, is the B protein of quinolinate synthetase. J Biol Chem (1982) 1.28
Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system. Surg Endosc (2002) 1.28
Recurrence in early gastric cancer. Surgery (1990) 1.28
Early gastric carcinoma in Japanese patients under 30 years of age. Br J Surg (1985) 1.27
Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol (2001) 1.27
Laparoscopic hepatic resection for hepatocellular carcinoma. Surg Endosc (1995) 1.27
Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res (1997) 1.27
Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res (1991) 1.27
Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res (2000) 1.26
Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol (1993) 1.25
Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer (1994) 1.25
An aneurysm of the right gastroepiploic artery. J Cardiovasc Surg (Torino) (1997) 1.25